EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Ferroptosis resistance in cancer cells: nanoparticles for combination therapy as a solution

Kodzo Prosper Adzavon, Weijian Zhao, Xuesong He, Wang Sheng

Frontiers in Pharmacology · 19.06.2024 · 15

DOI: 10.3389/fphar.2024.1416382 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 19.06.2024. Verfasst von Kodzo Prosper Adzavon und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemistry and Life Science, Beijing University of Technology, Beijing, China. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 209 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ferroptosis is a form of regulated cell death (RCD) characterized by iron-dependent lipid peroxidation. Ferroptosis is currently proposed as one of the most promising means of combating tumor resistance. Nevertheless, the problem of ferroptosis resistance in certain cancer cells has been identified. This review first, investigates the mechanisms of ferroptosis induction in cancer cells. Next, the problem of cancer cell resistance to ferroptosis, as well as the underlying mechanisms is discussed. Recently discovered ferroptosis-suppressing biomarkers have been described. The various types of nanoparticles that can induce ferroptosis are also discussed. Given the ability of nanoparticles to combine multiple agents, this review proposes nanoparticle-based ferroptosis cell death as a viable method of circumventing this resistance. This review suggests combining ferroptosis with other forms of cell death, such as apoptosis, cuproptosis and autophagy. It also suggests combining ferroptosis with immunotherapy.

Schlagwörter

Stichwörter der Autor:innen

cancer therapycombinatory therapyferroptosisferroptosis resistancenanoparticles

Autor:innen und Institutionen

  • College of Chemistry and Life Science, Beijing University of Technology, Beijing, China.

Zitieren

APA

Adzavon, K. P., Zhao, W., He, X., & Sheng, W. (2024). Ferroptosis resistance in cancer cells: nanoparticles for combination therapy as a solution. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1416382

Vancouver

Adzavon KP, Zhao W, He X, Sheng W. Ferroptosis resistance in cancer cells: nanoparticles for combination therapy as a solution. Frontiers in Pharmacology. 2024;15. doi:10.3389/fphar.2024.1416382

BibTeX
@article{Adzavon2024,
  author = {Adzavon, Kodzo Prosper and Zhao, Weijian and He, Xuesong and Sheng, Wang},
  title = {Ferroptosis resistance in cancer cells: nanoparticles for combination therapy as a solution},
  journal = {Frontiers in Pharmacology},
  year = {2024},
  volume = {15},
  doi = {10.3389/fphar.2024.1416382}
}
Kostenlos starten →